 Matt Piper, CBS News. The winners in the battle of the bulge, Munjaro and Zepbound. A study in the journal JAMA Internal Medicine finds people who take the weight loss drugs whose active ingredient is terzepatide, an appetite suppressing hormone, are three times more likely to shed 15% of their body weight than those on Ozempic and Wegovy. Deborah Rodriguez, CBS News.